Riederer, I., Bonomo, A. C., Mouly, V., Savino, W. :
Laminin therapy for the promotion of muscle regeneration
FEBS Lett, 2015 ; (SP) :
Publications (1181)
Lynn, S., Aartsma-Rus, A M, Furlong, P, Goemans, N., Deluca, A, Mayhew, A., Mercuri, E., Muntoni, F., Pohlschmidt, M, Verschuuren, J, Voit, T., Wells, D, Bushby, K., Vroom, E :
Measuring Clinical Effectiveness of Medicinal Products for the Treatment of Duchenne Muscular Dystrophy Neuromuscul Disord, 2015 ; 25 (1) : 96-105
Measuring Clinical Effectiveness of Medicinal Products for the Treatment of Duchenne Muscular Dystrophy Neuromuscul Disord, 2015 ; 25 (1) : 96-105
Rocheteau, P., Chatre, L., Briand, D., Mebarki, M., Jouvion, G., Bardon, J., Crochemore, C., Serrani, P., Lecci, P. P., Latil, M., Matot, B., Carlier, P. G., Latronico, N., Huchet, C., Lafoux, A., Sharshar, T., Ricchetti, M., Chretien, F. :
Sepsis induces long-term metabolic and mitochondrial muscle stem cell dysfunction amenable by mesenchymal stem cell therapy Nat Commun, 2015 ; 6 : 10145
Sepsis induces long-term metabolic and mitochondrial muscle stem cell dysfunction amenable by mesenchymal stem cell therapy Nat Commun, 2015 ; 6 : 10145
Heslop, E., Csimma, C., Straub, V., McCall, J., Nagaraju, K., Wagner, K. R., Caizergues, D., Korinthenberg, R., Flanigan, K. M., Kaufmann, P., McNeil, E., Mendell, J., Hesterlee, S., Wells, D. J., Bushby, K., Laforet, P. :
The TREAT-NMD advisory committee for therapeutics (TACT): an innovative de-risking model to foster orphan drug development Orphanet J Rare Dis, 2015 ; 10 : 49
The TREAT-NMD advisory committee for therapeutics (TACT): an innovative de-risking model to foster orphan drug development Orphanet J Rare Dis, 2015 ; 10 : 49
Buyse, G. M., Voit, T., Schara, U., Straathof, C. S., D'Angelo, M. G., Bernert, G., Cuisset, J. M., Finkel, R. S., Goemans, N., McDonald, C. M., Rummey, C., Meier, T. :
Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trial Lancet, 2015 ; 385 (9979) : 1748-1757
Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trial Lancet, 2015 ; 385 (9979) : 1748-1757
Philippi, S, Lorain, S, Beley, C, Peccate, C, Précigout, G, Spuler, S, Garcia, L :
Dysferlin rescue by spliceosome-mediated pre-mRNA trans-splicing targeting introns harbouring weakly defined 3′ splice sites Hum Mol Genet, 2015 ; 24 (14) : 4049-4060
Dysferlin rescue by spliceosome-mediated pre-mRNA trans-splicing targeting introns harbouring weakly defined 3′ splice sites Hum Mol Genet, 2015 ; 24 (14) : 4049-4060
Benveniste, O. :
Myopathies inflammatoires Rev Prat, 2015 ; 65 (5) : 607-12
Myopathies inflammatoires Rev Prat, 2015 ; 65 (5) : 607-12
Kalman, B., Monge, C., Bigot, A., Mouly, V., Picart, C., Boudou, T. :
Engineering human 3D micromuscles with co-culture of fibroblasts and myoblasts Comput Methods Biomech Biomed Engin, 2015 ; 18 Suppl 1 : 1960-1
Engineering human 3D micromuscles with co-culture of fibroblasts and myoblasts Comput Methods Biomech Biomed Engin, 2015 ; 18 Suppl 1 : 1960-1
Urtizberea, J. A., Behin, A. :
Myopathie GNE Med Sci (Paris), 2015 ; 31 Spec No 3 : 20-7
Myopathie GNE Med Sci (Paris), 2015 ; 31 Spec No 3 : 20-7
Goudot, F. X., Wahbi, K., Aissou, L., Sorbets, E., Siam-Tsieu, V., Eymard, B., Themar Noel, C., Devaux, J. Y., Dessault, O., Duboc, D., Meune, C. :
Reduced inotropic reserve is predictive of further degradation in left ventricular ejection fraction in patients with Duchenne muscular dystrophy Eur J Heart Fail, 2015 ; 17 (2) : 177-81
Reduced inotropic reserve is predictive of further degradation in left ventricular ejection fraction in patients with Duchenne muscular dystrophy Eur J Heart Fail, 2015 ; 17 (2) : 177-81
